Hepatitis B virus (HBV) is a parenterally transmissible pathogen for which specific measures for protecting medical staff and hospitalized patients are required. In particular, long-term hospitalized patients undergoing hemodialysis or cancer chemotherapy are at high risk for acquiring HBV infections. Leukemic patients were among the first in whom hepatitis B surface antigen (HBsAg) was detected (4) . This may be due to multiple venous punctures, transfusion of blood products, and destruction of mucous membranes in cases of polychemotherapeutic treatment for malignancies. Furthermore, these patients do not show clinical symptoms of HBV infections because of the low cytopathogenicity of the virus in the absence of a well-developed immune response (2, 8, 34, 45) . Routine monitoring of patients for HBV infections, therefore, should be carried out.
If more than one patient is positive, discrimination between sporadic and endemic HBV infections is required. For such a purpose, characteristic markers of the virus need to be demonstrated as identical or different in a group of infected patients. Antigenic variations within the surface antigen (HBsAg) of HBV have been long known, and these may be used to identify different strains of the virus (40) . Besides a common determinant designated "a," there are two determinant pairs, "d-y" and "w-r," which are mutually exclusive and which permit the recognition of four major subtypes of HBsAg, "adw," "adr,"" "ayw," and "ayr."' On the basis of additional minor determinants, eight subtypes of HBsAg were defined at an international workshop in Paris, France, in 1975 (5) . The antisera or monoclonal antibodies for the distinction of these epitopes are not generally avail-* Corresponding author. able and are difficult to prepare. Moreover, the definitive grouping of all known serologic subtypes by comparing their gene sequences is very complex and exceeds by far the complexity of determining the few single-base exchanges which encode the determinants d or y and w or r (26) . The antigenic characteristics of HBsAg can be correlated to point mutations within the S gene (29) . By using the correlations between HBsAg subtype and the S-gene sequence, the polymerase chain reaction (PCR) (36) has been previously applied to determine HBV subtypes (27, 39, 46) . However, most point mutations are difficult to discriminate by PCR. Additional procedures like DNA sequencing (46) and restriction endonuclease digestion (39) are required or at least three different PCR sets are needed to type a single sample (27) .
The genetic differences between HBV subtypes are not limited to the S gene. They are found all over the HBV genome, with the highest variations within the pre-S region. There is no stringent correlation between the phenotypic HBsAg markers and sequence variation outside the S gene. But such a correlation between genetic and phenotypic markers is not required for epidemiological studies Another serum sample in our multiplex PCR study was derived from one of our patients with leukemia who had been determined to be an HBsAg carrier by routine screening in 1991 during the first month of anticancer therapy. Furthermore, 25 serum samples which had been taken from mothers in Yaounde, Cameroon, at the time of their babies' births were typed by multiplex PCR. This number of sera had been positive for HBV DNA by PCR in a previous study that used a total number of 109 maternal serum samples (13) . Six positive serum samples taken from the babies at the age of 6 months were also subjected to PCR genotyping. All sera used in this study had been drawn in 1990 and 1991, except for those from the patients in the pediatric oncology unit who had not become HBV carriers. With these patients, their latest HBsAg-positive sera were analyzed. Prior to being used, the sera had been stored at -20°C.
For validation of our assay, four reference serum samples of known HBs subtype and two negative control serum samples were used. The HBsAg determinant d was assayed by immunodiffusion with monoclonal antibody C14/02 (12b), and the subtype determinant y was determined by immunodiffusion with a polyvalent guinea pig antiserum raised against purified ay HBsAg and absorbed against HBsAg of subtype ad (12a). In addition, the HBsAg subtypes of the four reference serum samples were determined by DNA sequencing of the S gene and the pre-S region of the viral genome. The subtypes of the reference sera were adw (serum Rl), adw4 (serum R2), ayw (serum R3), and adr (serum R4). Every sample included in this study was analyzed twice to prove the reproducibility of the results.
Primer selection. PCR primers were synthesized with an Applied Biosystems oligonucleotide synthesizer (Applied Biosystems, Inc., Foster City, Calif.) and purified by highperformance liquid chromatography. To achieve maximal sensitivity, a nested PCR protocol was used (11, 18, 41) . The PCR primer sequences shown in Table 1 were chosen on the basis of an alignment of 20 HBV DNA sequences accessible from the EMBL Data Library (Heidelberg, Germany) and the sequences of the reference sera (3, 7, 9, 10, 19-21, 28-30, 32, 35, 38, 42-44) . The outer primers for the first PCR round spanned regions of the HBV genome which are highly conserved among different HBV strains flanking the pre-S segment at positions 2820 to 2845 and 191 to 168 in the case of an HBV genome size of 3,221 bp (7, 21, 32, 43) . These are designated P1 and P2 in Table 1 . They exhibited at most one mismatch to the different subtypes of HBV DNA sequences listed in Table 1 . Therefore, all subtypes of HBV DNA should be amplified during the first round of PCR. The inner primers for the second round of the nested PCR protocol were designed to discriminate between different groups of HBV genotypes. Furthermore, the general advantages of nested PCR resulted in increases of sensitivity and specificity (1, 11, 31) . The sequences of the second-round primers shown in Table 1 were conserved within one group of HBV genomes but were very different from the other HBV sequences. Furthermore, the second-round primers generated different sizes of PCR products which were easily distinguishable by agarose gel electrophoresis. For the HBsAg subtype ayw-encoding genomes, this goal was reached with primers P3-P4, as shown by the distribution of matches and mismatches to different subtype sequences in Table 1 . For genome subtypes expressing HBsAg subtype determinant r, primers P7-P8 were selected. In the case of adw, however, no primer sequences were found within the pre-S region, which could detect all adw sequences and discriminate adw from the other HBV subtypes at the same time. To overcome these difficulties, the following strategy was developed. At first, a pair of primers (P5-P6) was selected which (Fig. 1) . DNA extraction. One milliliter of the patients' sera was diluted with 3 ml of phosphate-buffered saline, and the HBV particles were pelleted by ultracentrifuging through a cushion of 0.5 ml of 10% sucrose (Beckman SW6OTi rotor, 2 h, 4°C, 50,000 rpm). The pellets were treated with proteinase K in the presence of sodium dodecyl sulfate as previously described (33) . HBV DNA was purified by ion-exchange chromatography with a Quiagen 20 column (Diagen, Dusseldorf, Germany) according to the manufacturer's protocol (6) . However, more simplified methods of HBV DNA purification would have been applicable (27) if samples had not been heparinized (17) . The amount of DNA corresponding to 1 ml of serum was dissolved in 20 ,ul of sterile water, aiid 1 p.1 was subjected to PCR. A 10-1 to 10-7 dilution of these samples was used in experiments to determine the sensitivity of the PCR protocol and to rule out any effects of different template concentrations on the final agarose gel band pattern.
DNA amplification. PCR was performed with a Bio-Med Thermocycler 60 (Bio-Med, Theres, Germany) with a GeneAmp kit (Perkin Elmer, Uberlingen, Germany). After an initial melting step (5 min at 94°C), the enzyme was added and 35 amplification cycles of 60 s at 94°C, 120 s at 60°C, and 120 s at 74°C were carried out in a 50-,ul final volume containing 4 pmol of each primer during the first round of the nested PCR. The rather high number of 35 cycles was chosen during the first round to drive the PCR into the linear phase of amplification when the amount of primers or enzyme became limiting. By this method, different template concentrations should become compensated prior to the secondround PCR, since smaller amounts of template will be amplified exponentially during more cycles before the plateau phase of the PCR is reached. Such a compensation step should reduce the possible influence of differences in the primary template concentrations on the final results after the second-round multiplex PCR. One microliter of the firstround product was subjected to the second round of PCR. This round differed from the first round of PCR by the number of cycles, which was reduced to 25, the amount of primer (20 pmol Because of a gap of up to 33 nucleotides near the 3' end of P1, fragments initiated by this primer may vary in size. +GAP indicates the presence of 33 nucleotides, whereas -GAP indicates their absence. Gaps of fewer than 33 nucleotides can also be found in some HBV genomes, which lead to further size variation in PCR products primed by P1. The gel patterns obtained from the reference sera and from the Cameroonian serum M61 are shown schematically as a boxed set of lanes (Fig. 2) . LHBs, large HBs protein.
gene and the pre-S region of the HBV genome. Furthermore, the pre-S region was sequenced in 10 out of 54 serum samples from endemic infections among children with malignancies to prove the identity of the HBV genome in these patients and also in a serum sample from a Cameroonian mother with a unique gel pattern after PCR typing. For this purpose, PCR was performed according to the first-round protocol, but the primer concentration was increased 10-fold and recognition sites for the restriction enzymes Sall and Bcll were added to the PCR primers to facilitate cloning. PCR products were cloned into the plasmid vector pUC19 with the SalI and BamHI restriction sites within the polylinker region (24) . Plasmid preparations from single colonies were sequenced in both directions with a Sequenase kit (Pharmacia, Freiburg, Germany) (37) . In order to avoid PCR artifacts, two different clones were sequenced from each patient's serum.
RESULTS
All sera from the 55 children with malignancies were subjected successfully to nested PCR with the multiplex primer set in the second round. By agarose gel analysis of the amplificate, an identical pattern with two bands was obtained from all 54 samples taken from the children who had been infected during the hospital endemia. The results for three of these samples are shown in Fig. 2 . This pattern was identical to the result from the reference serum R3 expressing the HBsAg subtype ayw. The sizes of these two bands corresponded well to the expected sizes of 486 and 521 bp for reference serum R3, suggesting that the fragment amplification indeed was primed by P3-P4 and P1-P4, respectively (Fig. 1) . Furthermore, the identities of the PCR products obtained from these 54 children were confirmed by DNA sequencing of the pre-S region in 10 cases.
In contrast, the serum from the child who had been diagnosed as an HBV carrier 5 years later revealed a different pattern with three bands: two major bands and a third band of a lower intensity. In Fig. 2 , it is shown as reference serum Rl, which had been typed as adw serologically. As there are two sense and two antisense primers able to initiate DNA polymerization, for such an adw genome four bands can be expected. The calculated sizes are 341 bp (primed by P5-P6), 378 bp (P5-P4), 517 bp (P1-P6), and 554 bp if P1 and P4 initiate DNA polymerization ( Fig. 1 and 2) . The 517-bp fragment was less abundant than the two small fragments, and the 554-bp fragment was hardly visible at all, suggesting that priming by P5-P6 and P5-P4 was clearly favored.
A pattern of two stronger and two very faint bands was seen for reference serum R4 expressing subtype adr (Fig. 2) . For the adr and ayr sequences listed in Table 1 , the fragment sizes to be expected after PCR amplification are as follows: 411 bp (P7-P8), 515 bp (P7-P4), 450 bp (P1-P8), and 554 bp (P1-P4) (Fig. 1) . Priming by P7-P8 and P7-P4 appeared to be clearly favored. This suggests that the inner primer P7 may suppress amplification starting at the outer primer P1.
The adw4-positive reference serum R2 revealed only one clearly visible band at the 517-bp position, probably primed by P1-P6, and a very faint band of a larger size, probably primed by P1-P4 ( Fig. 1 and 2 ). This means that the universal primer P1 indeed was necessary in this case to obtain a positive result after the second-round PCR, because priming by the other sense primers (P3, P5, and P7) was inefficient.
The sera from Cameroon revealed a pattern identical to that for reference serum R3 in about 71% (22 out of 31) of the cases, which is in accordance with the predominance of subtype ayw in that area (23) . A pattern like M70 (Fig. 2) (15, 25, 27, 39, 40, 46) . Methods using the highly sensitive PCR possess some advantages over other procedures, as they are still able to detect and to type HBV DNA in low-viremic subjects (41) . The nested PCR protocol with a multiplex primer set described in this paper further simplifies screening for endemic HBV transmission. It combines highly sensitive detection of HBV infectivity and HBV genotyping without the need for further time-consuming procedures such as digestion by restriction endonucleases (46) or DNA sequencing (39) . Furthermore, these data show that a multiprimer PCR protocol generates more differentiated results in HBV genotyping than other PCR-based methods because of the competitive effects between different primers which not only result in the presence or absence of bands on an agarose gel but also lead to different band intensities ( Fig. 1 and 2 ). Certainly, this is an advantage in epidemiologic studies, but on the other hand, it means that the gel patterns generated by our protocol do not exactly reflect HBsAg subtypes or the four HBV genotypes, A to D, previously defined (26, 29) . On the basis of published sequence data ( (29) .
In a multiplex PCR protocol, there are several points that have to be considered which may affect primer-template affinities and competition between different primers of the same sense. First, the melting temperature of primer-template complexes has a major influence on the efficiency of amplification. It is dependent on the length of the primer, the relative amount of G or C nucleotides in comparison to A or T nucleotides, and the number of mismatches to the target sequence. As there are two primers required in each PCR amplification, the primer-template affinities of both primers have to be multiplied with regard to the efficiency of amplification. This means that a reduction in primer-template affinity to 50% in each primer should theoretically result in only 25% product amplification efficiency. Second, the positions of primer-template mismatches and the kinds of mismatches are important. Mismatches at the 3' end are more relevant than mismatches at the 5' terminus of a primer. A mismatch caused by a thymidine residue within the 3'-terminal primer sequence has fewer consequences than mismatches caused by other nucleotides (12) . Third, the relative position of the primers to one another is of relevance. If, for instance, there are two primers of the same sense and the same affinity to the template competing with one antisense primer, the one sense primer located more closely to the antisense primer has an advantage if the reaction is not limited by too-low primer concentrations (Fig. 2, reference serum R4 ). Theoretically, if both sense primers bind at one template molecule at the same time, the strand elongation initiated by the outer primer will stop at the position of the inner primer, as this primer already blocks the template molecule. Fourth, the annealing temperature used in a multiplex PCR has to be calculated well, so that different primer-template affinities clearly result in different amounts of final amplication products. An annealing temperature that is too low will mask the discriminatory effects of different primers. An annealing temperature that is too high will prevent any amplification at all. In summary, an optimal multiplex PCR primer set cannot only be calculated theoretically; it needs further empirical evaluation.
The application of such a multiplex PCR protocol will not be limited to subtyping of HBV in populations at high risk for HBV infections. Such a protocol might also be adapted to genomes of other infectious agents showing a suitable degree of sequence variability.
